American National Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.8K | Hold |
70
| – | – | ﹤0.01% | 411 |
|
|
2025
Q1 | $44.4K | Buy |
+70
| New | +$44.4K | ﹤0.01% | 346 |
|
|
2023
Q3 | – | Sell |
-10
| Closed | -$7.19K | – | 635 |
|
|
2023
Q2 | $7.19K | Hold |
10
| – | – | ﹤0.01% | 436 |
|
|
2023
Q1 | $8.22K | Hold |
10
| – | – | ﹤0.01% | 412 |
|
|
2022
Q4 | $7K | Sell |
10
-3
| -23% | -$2.1K | ﹤0.01% | 408 |
|
|
2022
Q3 | $9K | Sell |
13
-28
| -68% | -$19.4K | ﹤0.01% | 376 |
|
|
2022
Q2 | $24K | Buy |
41
+31
| +310% | +$18.1K | 0.01% | 235 |
|
|
2022
Q1 | $7K | Buy |
+10
| New | +$7K | ﹤0.01% | 338 |
|
|
2021
Q2 | – | Sell |
-10
| Closed | -$5K | – | 312 |
|
|
2021
Q1 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 232 |
|
|
2017
Q1 | – | Sell |
-4
| Closed | -$1K | – | 314 |
|
|
2016
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 273 |
|